[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"urodynamic-exam\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:urodynamic-exam":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,47,74],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100634622","impact-of-cmg-vs-vcmg-in-recurrent-stress-incontinence--a-pilot-study-100634622",false,"NCT07542080","Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study","Impact of Urodynamic and Video-urodynamic Testing on Surgical Outcomes in Women With Recurrent Urinary Incontinence","Inclusion Criteria:\n\n* competent (able to consent)\n* adult women (over 18 years old)\n* with recurrent stress urinary incontinence\n\nExclusion Criteria:\n\n* women who are pregnant\n* unfit for surgery\n* body mass index (BMI) over 35\n* background of pelvic radiotherapy or relevant neurogenic disease that would put them at risk of neurogenic bladder","FEMALE","18 Years","100 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","To asses feasibility of a prospective randomised trial comparing the outcomes of surgery for recurrent urinary incontinence after video-urodynamic(VCMG)and urodynamic(UDS)investigations. One of the greatest challenges for clinicians is the lack of correlation between bothersome urinary symptoms and the underlying urinary tract dysfunction. This has led to the development of several investigations aimed at improving diagnostic accuracy, with UDS and VUDS being the most noteworthy. Despite the heavy reliance on these invasive tests by clinicians, their indications and efficacy remain controversial and supporting literature data is scarce and nonvalidated. The investigators will perform a prospective randomised study of 30 women referred to our tertiary urological services at University College London Hospitals (UCLH) for treatment of recurrent stress urinary incontinence. The women will be investigated with either UDS or VUDS prior to receiving medical and surgical treatment tailored to the identified underlying urinary tract dysfunction. Adult women with symptoms suggestive of recurrent stress urinary incontinence after failed continence surgery will be included. Women who are pregnant, unfit for surgery, have a background of pelvic radiotherapy or relevant neurogenic disease that would put them at risk of neurogenic bladder will be excluded. UDS\u002FVUDS will be performed under the care of Functional, Reconstructive and Adolescent Urology (FFA) Urology Service at UCLH adhering to standardised protocols. Treatment will be provided by FRA Team at UCLH. The primary outcome is assessment of symptoms of urinary incontinence by using validated questionnaires. Results will be correlated with patient characteristics, X-ray exposure, patient experience metrics, outcome and expenses to determine in which sub-populations performing UDS or VUDS has a higher impact on outcomes and when they should be avoided.",[27,28,29],"Stress Incontinence Female","Urodynamic Exam","Urodynamic Stress Incontinence",[31,32,33],"urodynamics","videourodynamics","stress incontinence","RECRUITING","2026-04-28",{"date":37,"type":38},"2026-05-05","ACTUAL",{"date":40,"type":38},"2025-10-06",{"date":42,"type":21},"2027-06-06",{"name":44,"class":45},"University College, London","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":54,"minAge":55,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":46},"100585703","e-sense-normal-values-of-urodynamic-pressures-using-e-sense-catheters-100585703","NCT06905808","e-Sense® Normal Values of Urodynamic Pressures Using e-Sense® Catheters","ESNS-01","Inclusion Criteria:\n\n* Subjects medically indicated for Urodynamic procedure between ages 20-35 or \\> 50 years old (equally split male and female)\n* Due to aging and giving birth significantly affecting the urethra:\n* Female subjects 20-35 should be nulliparous.\n* Female subjects \\> 50 years old should have given birth to at least one child vaginally. Further caesarian births would not mean exclusion from the study.\n* Subjects with range of BMI values\n* Subject provides written authorization and\u002For consent per institution or geographical requirements\n\nExclusion Criteria:\n\n* Subjects with cognitive or psychiatric conditions that interfere with or precludes direct and accurate communication regarding the study, giving informed consent\n* Any anal \u002F rectal symptoms and\u002For surgery\n* Pregnant women\n* Subjects with active untreated bladder infections (not including patients with asymptomatic bacteruria)\n* Subjects having greater than 300 mL post void residual on the clinic visit uroflowmetry test","ALL","20 Years",{"count":57,"type":21},40,"OBSERVATIONAL","In this post-market observational study, subjects referred to urodynamic testing will be approached to enroll in a clinical study to define the normal range of pressure values utilizing e-Sense® catheters. Urodynamic test results using the study devices will be provided back to the study sponsor for test interpretation and to publish. The urodynamic information collected using the study devices will be used in the UDS test interpretation for each subject enrolled, unless there is a reason to believe the test should be repeated (i.e. inconclusive results).",[61,28],"Lower Urinary Track Symptoms",[63,61],"Urodynamic","2026-04-23",{"date":66,"type":38},"2026-04-29",{"date":68,"type":38},"2025-08-15",{"date":70,"type":21},"2026-12",{"name":72,"class":73},"Laborie Medical Technologies Inc.","INDUSTRY",{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":54,"minAge":17,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":22,"phases":84,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":46},"100512216","does-position-influence-the-diagnosis-of-detrusor-overactivity-in-a-neurological-population-100512216","NCT05949567","Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population","Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population - a Concordance Study Between Lying and Sitting Position","Cysto-position","Inclusion Criteria:\n\n* Patient with MS or neurologically confirmed Parkinson's disease, with indication for urodynamic assessment - 1st assessment\n* Clinical overactive bladder syndrome with USP overactive bladder sub-score \\> or = 4 - Age ≥18 years\n* In men: no prostatic hypertrophy on ultrasonography\n* In women: no stress urinary incontinence (SUI); USP SUI subscore ≤ 2\n* Affiliated with a social security scheme (excluding AME).\n* Free and informed written consent\n\nExclusion Criteria:\n\n* Opposition to the performance of a Urodynamic exam as part of treatment",{"count":83,"type":21},160,[24],"ICS (International Continence Society) recommendations published in 2017 recommend performing urodynamic examinations in the sitting or standing position. These recommendations are based on a review of the literature published in 2008, which has several limitations: heterogeneous populations, old and non-harmonized techniques, and very few neurological patients. It seems appropriate to focus on neurological patients and to examine the influence of position on the detection of detrusor overactivity in these patients.\n\nThe point here is to reexamine the ICS recommendations, which are not designed for neurological patients. Indeed, many patients suffering from Multiple Sclerosis (MS) or Parkinson's disease are unable to sit or stand for the duration of the urodynamic examination. The investigators would like to assess whether exploring sphincter disorders in the supine position is still interpretable.\n\nThis would enable us to define ICS good practice recommendations for a neurological population.",[28,87],"Neurologic Disorder",[89,90,91],"Urodynamic exam","detrusor overactivity","positon","2026-04-14",{"date":94,"type":38},"2026-04-17",{"date":96,"type":38},"2024-04-02",{"date":98,"type":21},"2027-04-02",{"name":100,"class":45},"Assistance Publique - Hôpitaux de Paris"]